This inventor holds 1 USPTO granted patent. Top assignee: Kali-Chemie Pharma Gmbh. Active years: 1992.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1992
Title: The Innovative Contributions of Kurt Burow
Introduction
Kurt Burow is a notable inventor based in Hanover, Delaware. He has made significant contributions to the field of pharmaceuticals, particularly in diuretic treatments. His work has led to advancements that benefit mammals in need of effective diuretic solutions.
Latest Patents
Kurt Burow holds a patent for a method of diuretic treatment utilizing 3,7-diazabicyclo[3,3,1]nonane compounds. This innovative method involves administering an effective diuretic amount of a diuretically active 3,7,9,9-tetrasubstituted 3,7-diazabicyclo[3,3,1]nonane compound. The patent also includes diuretic pharmaceutical compositions containing these compounds, as well as previously unknown diuretically active variants that feature an optionally substituted phenylalkyl group in the 3-position.
Career Highlights
Kurt Burow is associated with Kali-Chemie Pharma GmbH, where he has been instrumental in developing new pharmaceutical solutions. His expertise in the field has led to the creation of innovative treatments that address specific medical needs.
Collaborations
Throughout his career, Kurt has collaborated with talented professionals such as Gerd Buschmann and Arman Farjam. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical innovations.
Conclusion
Kurt Burow's contributions to diuretic treatments exemplify the impact of innovative thinking in the pharmaceutical industry. His patent and collaborations highlight the importance of teamwork in advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile